High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Clinical trial NCT07177079 · RECRUITING
Trial details
- NCT number
- NCT07177079
- Sponsor
- Kittika Poonsombudlert
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2028-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.